A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tegoprazan Impurity 30 - Request Quote

Picture of Tegoprazan Impurity 30

Tegoprazan Impurity 30

SZ CAT No:SZ-T098036
CAS No
NA
Mol.F.
C27H25F2N3O3
Mol.Wt.
477.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Tegoprazan Impurity 30 is chemically 1-benzyl-5-(5,7-difluorochroman-4-yl)-4-hydroxy-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide. Tegoprazan Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Tegoprazan Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tegoprazan.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Tegoprazan Impurity 30

Purchase Tegoprazan Impurity 30

Tegoprazan Impurity 30 suppliers

Tegoprazan Impurity 30 manufacturers

Tegoprazan Impurity 30 price

Order Tegoprazan Impurity 30

Enquire Tegoprazan Impurity 30

Tegoprazan Impurity 30 cost

Tegoprazan Impurity 30 Supplier

Tegoprazan Impurity 30 Distributor

Tegoprazan Impurity 30 for Method Validation

Tegoprazan Reference Standard

Tegoprazan Impurity 30 for ANDA Filing

Tegoprazan Impurity 30 for Forced Degradation Studies

Tegoprazan Impurity 30 Identification Standards

Tegoprazan Impurity 30 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,